It is known that Nav1.5 expression in breast cancer cells is closely associated with the protein level of CD44, which correlates with poor outcomes of breast cancer (McFarlane et al., 2015; Nelson et al., 2015b). This evidence concerns the gene SCN5A and breast carcinoma.